ConductScience.org, home

Paper40064751

Compound PZ-1262, a 4-isoquinoline-sulfonamide analog of Brexpiprazole, produces potential antidepressant, anxiolytic and procognitive effects in rodent models.

Partyka A and 13 others. Pharmacol Rep, 2025. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Compound PZ-1262, a 4-isoquinoline-sulfonamide analog of Brexpiprazole, produces potential antidepressant, anxiolytic and procognitive effects in rodent models. Papers, record 40064751. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40064751

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Compound PZ-1262, a 4-isoquinoline-sulfonamide analog of Brexpiprazole, produces potential antidepressant, anxiolytic and procognitive effects in rodent models.
PubMed
Journal
Pharmacol Rep
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2025-05-30
PubMed

Authors14

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antidepressive AgentsMajor topic
Anti-Anxiety AgentsMajor topic
QuinolonesMajor topic
ThiophenesMajor topic
SulfonamidesMajor topic
IsoquinolinesMajor topic
Nootropic AgentsMajor topic
Animals
Male
Rats
Mice
Antipsychotic Agents
Disease Models, Animal
Cognition
Humans
Behavior, Animal

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
UGA POIG.01.03.01-12-063/09-00project Prokog, European Fund of Regional Development (EFRD)PubMed

Source PubMed

Download CSV of grants

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Erratum in40445584Correction: Compound PZ-1262, a 4-isoquinoline-sulfonamide analog of Brexpiprazole, produces potential antidepressant, anxiolytic and procognitive effects in rodent models.https://conductscience.org/library/papers/40445584

Source PubMed

Download CSV of comments and corrections

References43

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
123810019Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis.Lancet2013https://conductscience.org/library/papers/23810019PubMed
229407591Novel multi-target azinesulfonamides of cyclic amine derivatives as potential antipsychotics with pro-social and pro-cognitive effects.Eur J Med Chem2018https://conductscience.org/library/papers/29407591PubMed
321394633Comparative pharmacology of antipsychotics possessing combined dopamine D2 and serotonin 5-HT1A receptor properties.Psychopharmacology (Berl)2011https://conductscience.org/library/papers/21394633PubMed
425448429Combined serotonin (5-HT)1A agonism, 5-HT(2A) and dopamine D₂ receptor antagonism reproduces atypical antipsychotic drug effects on phencyclidine-impaired novel object recognition in rats.Behav Brain Res2015https://conductscience.org/library/papers/25448429PubMed
537386328The Serotonin 1A (5-HT1A) Receptor as a Pharmacological Target in Depression.CNS Drugs2023https://conductscience.org/library/papers/37386328PubMed
623757185Serotonin 5-HT1A receptors as targets for agents to treat psychiatric disorders: rationale and current status of research.CNS Drugs2013https://conductscience.org/library/papers/23757185PubMed
724501158The procognitive effects of 5-HT6 receptor ligands in animal models of schizophrenia.Rev Neurosci2014https://conductscience.org/library/papers/24501158PubMed
821115035The treatment of cognitive impairment in schizophrenia.Pharmacol Biochem Behav2011https://conductscience.org/library/papers/21115035PubMed
919337725Amisulpride is a potent 5-HT7 antagonist: relevance for antidepressant actions in vivo.Psychopharmacology (Berl)2009https://conductscience.org/library/papers/19337725PubMed
10189481245-HT7 receptor deletion enhances REM sleep suppression induced by selective serotonin reuptake inhibitors, but not by direct stimulation of 5-HT1A receptor.Neuropharmacology2009https://conductscience.org/library/papers/18948124PubMed
1122659581Microinjection of the 5-HT7 receptor antagonist SB-269970 into the rat brainstem and basal forebrain: site-dependent effects on REM sleep.Pharmacol Biochem Behav2012https://conductscience.org/library/papers/22659581PubMed
1216613552The dopamine D3 receptor: a therapeutic target for the treatment of neuropsychiatric disorders.CNS Neurol Disord Drug Targets2006https://conductscience.org/library/papers/16613552PubMed
1324488407α2-Adrenoceptors are targets for antipsychotic drugs.Psychopharmacology (Berl)2014https://conductscience.org/library/papers/24488407PubMed
1426899451Mechanism of action of brexpiprazole: comparison with aripiprazole.CNS Spectr2016https://conductscience.org/library/papers/26899451PubMed
1523279866Antidepressant and antipsychotic activity of new quinoline- and isoquinoline-sulfonamide analogs of aripiprazole targeting serotonin 5-HT₁A/5-HT₂A/5-HT₇ and dopamine D₂/D₃ receptors.Eur J Med Chem2013https://conductscience.org/library/papers/23279866PubMed
1627326337N1-Azinylsulfonyl-1H-indoles: 5-HT6 Receptor Antagonists with Procognitive and Antidepressant-Like Properties.ACS Med Chem Lett2016https://conductscience.org/library/papers/27326337PubMed
1730188719Amino Acid Hot Spots of Halogen Bonding: A Combined Theoretical and Experimental Case Study of the 5-HT7 Receptor.J Med Chem2018https://conductscience.org/library/papers/30188719PubMed
1828529043The impact of the halogen bonding on D2 and 5-HT1A/5-HT7 receptor activity of azinesulfonamides of 4-[(2-ethyl)piperidinyl-1-yl]phenylpiperazines with antipsychotic and antidepressant properties.Bioorg Med Chem2017https://conductscience.org/library/papers/28529043PubMed
1925131522Novel tricyclic[2,1-f]theophylline derivatives of LCAP with activity in mouse models of affective disorders.J Pharm Pharmacol2014https://conductscience.org/library/papers/25131522PubMed
2034467765Structure-Based Design and Optimization of FPPQ, a Dual-Acting 5-HT3 and 5-HT6 Receptor Antagonist with Antipsychotic and Procognitive Properties.J Med Chem2021https://conductscience.org/library/papers/34467765PubMed

See all 43 referencesDownload CSV of references

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
HTR1A3350PubTator's text mininghttps://conductscience.org/library/genes/3350NCBI Gene
HTR2A3356PubTator's text mininghttps://conductscience.org/library/genes/3356NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Cited by
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40064751

GET https://conductscience.org/api/papers/v1/40064751/references?page=2